Showing results (181-190 of 309) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|June 7, 2013
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE studyBernard Combe, Bhaskar Dasgupta, Ingrid Louw, et al.
Cardiovascular Research|November 13, 2004
Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic miceXu Peng, Hiroki Ueda, Hongming Zhou, et al.
Rheumatology (Oxford, England)|May 13, 2020
Early variation of ultrasound halo sign with treatment and relation with clinical features in patients with giant cell arteritisCristina Ponte, Ana Sofia Serafim, Sara Monti, et al.
Arthritis Care & Research|May 20, 2014
Patient and physician expectations of add-on treatment with golimumab for rheumatoid arthritis: relationships between expectations and clinical and quality of life outcomesBhaskar Dasgupta, Bernard Combe, Ingrid Louw, et al.
BMJ Open|September 8, 2017
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol studyGowrie Balasubramaniam, Trisha Parker, David Turner, et al.
Anticancer Research|December 31, 2021
High-purity Isolation for Genotyping Rare Cancer Cells from Blood Using a Microfluidic Chip Cell SorterMio Ikeda, Yasuhiro Koh, Jun Oyanagi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2021
[Resection of the Acinar Cell Carcinoma of the Pancreas with Lymph Node Recurrence along the Lesser Curvature of the Stomach-A Case Report]Shigekazu Yokoyama, Hideo Ota, Hiroki Ueda, et al.
Internal Medicine (Tokyo, Japan)|December 22, 2010
High COPD prevalence in patients with liver diseaseYoshiaki Minakata, Hiroki Ueda, Keiichiro Akamatsu, et al.
Scientific Reports|May 10, 2023
MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimensKohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Cancer Science|September 12, 2021
Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancersYoshiki Murase, Hiroaki Ono, Kosuke Ogawa, et al.
Pageof 31